Solid Biosciences Inc.

NASDAQ: SLDB · Real-Time Price · USD
6.12
-0.05 (-0.81%)
At close: Aug 15, 2025, 3:59 PM
6.16
0.74%
After-hours: Aug 15, 2025, 07:15 PM EDT

Solid Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
3.12M 3.12M 3.12M 4.74M 4.74M 4.74M 4.74M 8.09M 8.09M 14.26M 16.19M 11.25M 14.79M 12.21M 13.62M 108.78M 105.25M 101.65M
Cost of Revenue
1.69M 2.54M 2.46M 2.55M 2.74M 2.21M 2.96M 2.91M 2.76M 2.78M 2.41M 46.01M 60M 74.79M 88.29M 93.3M 94.92M 92.86M
Gross Profit
-1.69M -2.54M -2.46M -2.55M -2.74M -2.21M -2.96M 5.19M 5.34M 11.49M 13.78M -34.77M -45.22M -62.58M -74.67M 15.48M 10.32M 8.79M
Operating Income
-156.82M -142.92M -129.73M -112.1M -100.03M -99.08M -104.25M -110.89M -108.91M -107.45M -100.79M -90.54M -87.44M -80.74M -72.25M -74.95M -78.14M -78.43M
Interest Income
9.52M 9.12M 9.47M 9.2M 8.73M 8.23M 7.25M 5.59M 4.47M 2.71M 1.03M 1.09M 357K 64K 64K n/a n/a n/a
Pretax Income
-154.08M -139.68M -124.7M -102.44M -90.69M -90.25M -96.02M -90.83M -90.26M -90.72M -85.98M -89.44M -87.01M -80.62M -72.19M -74.94M -78.2M -78.5M
Net Income
-154.08M -139.68M -124.7M -102.44M -90.69M -90.25M -96.02M -71.08M -69.79M -69.96M -65.22M -88.43M -86.72M -80.62M -72.19M -74.94M -78.2M -78.5M
Selling & General & Admin
35.4M 34.45M 33.3M 30.4M 28.95M 27.75M 27.16M 28.56M 29.27M 29M 28.95M 28.54M 28.56M 28.47M 27.14M 25.55M 23.59M 22.35M
Research & Development
121.43M 108.47M 96.43M 81.11M 70.49M 70.81M 76.56M 82.4M 79.7M 83.11M 78.42M 71.72M 72.14M 64.48M 58.74M 59.87M 61.49M 59.42M
Other Expenses
-1.28M -895K -815K -327K -327K -62K 547K 6.21M 6.93M 6.95M 6.71M 1.03M 360K 73K 15K 1.98M 1.91M 1.91M
Operating Expenses
155.54M 142.02M 128.91M 111.18M 99.11M 98.23M 103.73M 110.96M 108.98M 112.1M 107.37M 100.27M 100.7M 92.95M 85.87M 85.42M 85.07M 81.77M
Interest Expense
285K 313K 340K 265K 183K 206K 111K 111K 111K n/a n/a n/a n/a 13K 27K 43K 63K 63K
Selling & Marketing Expenses
n/a n/a n/a -587K -587K -587K -587K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
156.82M 142.92M 129.73M 112.1M 100.03M 99.15M 104.31M 110.96M 108.98M 112.1M 107.37M 100.27M 100.7M 92.95M 85.87M 85.42M 85.07M 81.77M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a -19.75M -20.47M -20.76M -20.8M -1.12M -399K -96K -52K 11K 12K -1K
Shares Outstanding (Basic)
94.14M 66.34M 40.82M 41.44M 40.93M 38.16M 20.39M 20.06M 19.66M 19.57M 8.02M 7.53M 7.52M 7.51M 7.36M 7.48M 7.33M 5.95M
Shares Outstanding (Diluted)
94.14M 66.34M 40.82M 41.44M 40.93M 38.16M 20.39M 20.06M 19.66M 19.57M 8.02M 7.53M 7.52M 7.51M 7.49M 7.48M 7.49M 5.95M
EPS (Basic)
-2.84 -3.03 -3.08 -3.04 -3.3 -3.94 -4.84 -3.27 -4.83 -6.88 -8.71 -11.81 -11.6 -10.85 -10.33 -14.44 -18.64 -21.94
EPS (Diluted)
-2.84 -3.03 -3.08 -3.04 -3.3 -3.94 -4.84 -3.27 -4.83 -6.88 -8.71 -11.77 -11.56 -10.76 -10.24 -14.39 -18.59 -21.94
EBITDA
-154.77M -136.83M -121.9M -101.55M -89.7M -89.77M -94.76M -101.45M -101.75M -101.08M -96.87M -86.39M -82.97M -77.8M -69.29M -71.95M -75.13M -74.8M
EBIT
-153.8M -139.36M -124.36M -104.1M -92.44M -92.08M -97.94M -99.72M -99.87M -99.1M -94.4M -89.02M -85.92M -80.74M -72.25M -74.95M -78.14M -78.43M
Depreciation & Amortization
1.69M 2.54M 2.46M 2.55M 2.74M 2.21M 2.96M 2.91M 2.76M 2.78M 2.41M 2.63M 2.94M 2.94M 2.96M 3M 3.01M 3.63M